According to the latest clinical guidelines, Canadians should not be required to justify their need for HIV prevention medications to obtain them. Dr. Darrell Tan, a physician-scientist at St. Michael’s Hospital in Toronto and primary author of the guidelines, emphasizes that healthcare providers should be willing to prescribe these medications to any adult or adolescent who requests them without extensive personal inquiries.
In an interview with As It Happens host Nil Köksal, Tan highlighted the importance of the updated Canadian Medical Association Journal guidelines released on Monday. These guidelines offer recommendations and best practices for prescribing antiretroviral drugs for HIV prevention, the first update since 2017, aiming to address the increasing HIV infections in communities lacking access to healthcare and information.
Factors Contributing to High HIV Cases
The Public Health Agency of Canada reported 1,826 new HIV diagnoses in Canada in 2024, excluding 476 cases from Quebec not included in the federal report. While there was a slight decrease from the 2,434 cases in 2022, the overall trend has shown a steady rise in new HIV diagnoses since 2021, despite advancements in HIV treatment and prevention medications.
Dr. Tan expressed that every new HIV infection is preventable, advocating for the extensive use of highly effective and safe prevention tools. Medications like pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) play crucial roles in reducing HIV transmission risk.
Efforts are needed to increase the prescription of PrEP and PEP, as current practices show limited distribution due to doctors’ selective criteria based on reported high-risk behaviors. The guidelines acknowledge various barriers to disclosing HIV risk behaviors to healthcare providers, emphasizing the need for open discussions while encouraging proactive prescribing of HIV prevention drugs.
Furthermore, the guidelines emphasize the necessity for improved public health communication regarding these medications, underscoring the importance of awareness campaigns similar to those for flu and COVID-19 vaccinations.
